SCHEMBL12412349

SCHEMBL12412349

[C-]#[N+]c1cc2c(Oc3ccc(NC(=O)NC)c(Cl)c3)ccnc2cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.54
PDGFRA P16234 11/20 0.53
FGFR1 P11362 5/20 0.53
FLT1 P17948 4/20 0.53
FLT4 P35916 4/20 0.53
KIT P10721 4/20 0.53
RET P07949 3/20 0.53
PDGFRB P09619 3/20 0.53
RIPK2 O43353 2/20 0.53
STK10 O94804 2/20 0.53
ABL1 P00519 2/20 0.53
BCR P11274 2/20 0.53
EPHB2 P29323 2/20 0.53
SLC6A3 Q01959 2/20 0.53
DDR1 Q08345 2/20 0.53
MAP4K2 Q12851 2/20 0.53
PTK6 Q13882 2/20 0.53
DDR2 Q16832 2/20 0.53
AURKB Q96GD4 2/20 0.53
RIPK3 Q9Y572 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22535168 0.85 KDR (0.56) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL1891114 0.85 KDR (0.56) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL12412348 0.85 KDR (0.51) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL12412352 0.83 FGFR4 (0.50) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL1889995 0.83 KDR (0.54) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL1893858 0.81 KDR (0.53) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL12412355 0.81 KDR (0.47) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL12673679 0.80 KDR (0.67) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL12412351 0.80 FGFR2 (0.49) KDRPDGFRAFGFR1FLT1FLT4
SCHEMBL12411524 0.80 KDR (0.69) KDRPDGFRAFLT1KITAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 KDR 2687/4885PDGFRA 3131/4885FGFR1 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.